These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35651818)

  • 1. Protocol for a Pragmatic Trial of Pharmacotherapy Options Following Unsatisfactory Initial Treatment in OCD (PROCEED).
    Wang P; Gu W; Gao J; Wang C; Fang J; Hu M; Xiang H; Li B; Liu N; Tang W; Wang X; Jia Y; Li Y; Cheng Y; Tang Z; Simpson HB; Stein DJ; Wang Z
    Front Psychiatry; 2022; 13():822976. PubMed ID: 35651818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
    Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving beyond first-line treatment options for OCD.
    Paxos C
    Ment Health Clin; 2022 Oct; 12(5):300-308. PubMed ID: 36405507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.
    Ma ZR; Shi LJ
    Int J Clin Exp Med; 2014; 7(12):4897-905. PubMed ID: 25663986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine.
    Brar J; Sidana A; Chauhan N; Bajaj MK
    Prim Care Companion CNS Disord; 2022 Mar; 24(2):. PubMed ID: 35364630
    [No Abstract]   [Full Text] [Related]  

  • 6. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
    Mowla A; Boostani S; Dastgheib SA
    J Clin Psychopharmacol; 2016 Dec; 36(6):720-723. PubMed ID: 27811556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation.
    Rossi R; Niolu C; Siracusano A; Rossi A; Di Lorenzo G
    Case Rep Psychiatry; 2020; 2020():2616492. PubMed ID: 32047692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?
    Sansone RA; Sansone LA
    Innov Clin Neurosci; 2011 Jun; 8(6):10-4. PubMed ID: 21779536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder in children and adolescents.
    Williams JS; Moore T; Collins CL; Thomas KA
    J Pediatr Pharmacol Ther; 2003 Jul; 8(3):177-86. PubMed ID: 23118677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial.
    Gowda SM; Narayanaswamy JC; Hazari N; Bose A; Chhabra H; Balachander S; Bhaskarapillai B; Shivakumar V; Venkatasubramanian G; Reddy YCJ
    Brain Stimul; 2019; 12(4):922-929. PubMed ID: 30808612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.
    Choi YJ
    J Am Acad Nurse Pract; 2009 Apr; 21(4):207-13. PubMed ID: 19366379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline Effects on Striatal Resting-State Functional Connectivity in Youth With Obsessive-Compulsive Disorder: A Pilot Study.
    Bernstein GA; Cullen KR; Harris EC; Conelea CA; Zagoloff AD; Carstedt PA; Lee SS; Mueller BA
    J Am Acad Child Adolesc Psychiatry; 2019 May; 58(5):486-495. PubMed ID: 30768407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment options for OCD.
    Fineberg NA
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
    Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
    J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internet-based psychotherapy in children with obsessive-compulsive disorder (OCD): protocol of a randomized controlled trial.
    Conzelmann A; Hollmann K; Haigis A; Lautenbacher H; Bizu V; App R; Nickola M; Wewetzer G; Wewetzer C; Ivarsson T; Skokauskas N; Wolters LH; Skarphedinsson G; Weidle B; de Haan E; Torp NC; Compton SN; Calvo R; Lera-Miguel S; Alt A; Hohnecker CS; Allgaier K; Renner TJ
    Trials; 2022 Feb; 23(1):164. PubMed ID: 35189937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.
    Cheer SM; Figgitt DP
    Paediatr Drugs; 2001; 3(10):763-81. PubMed ID: 11706925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.
    Ipser JC; Carey P; Dhansay Y; Fakier N; Seedat S; Stein DJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005473. PubMed ID: 17054260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.